TRCT
VIOV icon

Tower Research Capital (TRC)’s Vanguard S&P Small-Cap 600 Value ETF VIOV Stock Holding History

Tower Research Capital (TRC)’s Portfolio VIOV Stock Details VIOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$489 – 5603
2025
Q4 		$489 Buy
5
+2
+67% +$193 ﹤0.01% 4888
2025
Q3 		$286 Sell
3
-2
-40% -$183 ﹤0.01% 5037
2025
Q2 		$428 Buy
+5
New +$406 ﹤0.01% 5028
2024
Q4 		– Sell
-4
Closed -$370 – 6026
2024
Q3 		$370 Buy
+4
New +$357 ﹤0.01% 5357
2024
Q2 		– Sell
-2
Closed -$177 – 6027
2024
Q1 		$177 Sell
2
-53
-96% -$4.52K ﹤0.01% 5606
2023
Q4 		$4.87K Buy
55
+50
+1,000% +$3.93K ﹤0.01% 4904
2023
Q3 		$385 Hold
5
– – ﹤0.01% 5581
2023
Q2 		$411 Buy
+5
New +$395 ﹤0.01% 5653
2022
Q4 		– Sell
-7,956
Closed -$568K – 6414
2022
Q3 		$568K Buy
+7,956
New +$637K 0.01% 1048
2022
Q2 		– Sell
-4,614
Closed -$409K – 6549
2022
Q1 		$409K Sell
4,614
-29,348
-86% -$2.59M ﹤0.01% 1270
2021
Q4 		$3.06M Buy
33,962
+32,882
+3,045% +$2.98M 0.05% 300
2021
Q3 		$94K Sell
1,080
-8,500
-89% -$742K ﹤0.01% 2458
2021
Q2 		$874K Sell
9,580
-10,588
-52% -$957K 0.02% 760
2021
Q1 		$1.76M Buy
+20,168
New +$1.65M 0.03% 526
2020
Q3 		– Sell
-19,438
Closed -$1.01M – 5122
2020
Q2 		$1.01M Buy
+19,438
New +$945K 0.04% 519
2020
Q1 		– Sell
-2,546
Closed -$177K – 3951
2019
Q4 		$177K Buy
2,546
+368
+17% +$24.6K 0.01% 637
2019
Q3 		$141K Sell
2,178
-1,828
-46% -$116K 0.01% 1168
2019
Q2 		$257K Buy
4,006
+82
+2% +$5.25K 0.02% 754
2019
Q1 		$250K Buy
+3,924
New +$250K 0.02% 1036
2018
Q4 		– Sell
-200
Closed -$14K – 4399
2018
Q3 		$14K Buy
+200
New +$14.6K ﹤0.01% 2573
2016
Q2 		– Sell
-114
Closed -$6K – 5016
2016
Q1 		$6K Buy
+114
New +$5.09K ﹤0.01% 2568
2015
Q4 		– Sell
-1,190
Closed -$54K – 5085
2015
Q3 		$54K Buy
+1,190
New +$57.4K 0.01% 965

Other funds holding VIOV

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $761M AUM 18.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return

Tower Research Capital (TRC)'s VIOV Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Vanguard S&P Small-Cap 600 Value ETF (VIOV) in Q1 2026, closing a stake of 5 shares — an estimated $489 sold.

Tower Research Capital (TRC) first reported a position in VIOV in Q3 2015 and held it in 22 quarters. The position peaked at $3.06M in Q4 2021. 214 funds tracked by Wall St. Rank hold VIOV as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Vanguard S&P Small-Cap 600 Value ETF position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5 Vanguard S&P Small-Cap 600 Value ETF shares in Q1 2026, an estimated $489.
  • Tower Research Capital (TRC) first reported a position in Vanguard S&P Small-Cap 600 Value ETF in Q3 2015 and held it in 22 quarters.
  • Tower Research Capital (TRC)'s Vanguard S&P Small-Cap 600 Value ETF position peaked at $3.06M in Q4 2021.
  • 214 funds tracked by Wall St. Rank held Vanguard S&P Small-Cap 600 Value ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.